June 21st 2024, 3:27pm
From Don Omar announcing being cancer free to “General Hospital” star John York talking about treatment for his two cancers, here’s what’s going on in the oncology space this week.
June 19th 2024, 5:00pm
As a cancer survivor, I realize that life doesn’t always go the way we think it will, but it doesn’t erase the guilt.
June 17th 2024, 1:00pm
Approximately half of the patients with MDS who responded to treatment with Rytelo went a year without needing a blood transfusion, one expert explained.
June 7th 2024, 1:23pm
The Food and Drug Administration has approved Rytelo to treat certain patients with low- to intermediate-1 risk MDS with transfusion-dependent anemia.
June 3rd 2024, 7:00pm
Patients with myelodysplastic syndromes tended to have longer periods of time without needing a red blood cell transfusion when treated with Reblozyl.
June 3rd 2024, 1:00pm
The safety profile of 200 milligrams and 300 milligrams of oral Ongureg were similar in patients with lower- to intermediate-risk MDS.
May 15th 2024, 5:00pm
As a cancer survivor, I’m pleading for more research on cancer related fatigue.
May 10th 2024, 9:23pm
When possible, immune checkpoint inhibitors should be avoided in pregnant women with cancer due to lung inflammation and possible miscarriage, researchers found.
May 9th 2024, 7:30pm
An oncology nurse discusses what patients should know before BiTE therapy, and what they can do if they do not have a social support system.
May 3rd 2024, 1:00pm
For patients with blood cancers, CAR-T cell therapy has been a “mind-blowing” advancement for treatment in the cancer space.
Zyprexa Added to Standard Antiemetics Reduces Nausea, Vomiting in Radiation
Sasanlimab-BCG Combo May Delay Recurrence in Bladder Cancer
Personalized Vaccine Elicits Responses in Patients With Kidney Cancer
The Invisibility of Blood Cancers to Others